ProQR Therapeutics N.V. (PRQR)
1.41
-0.02 (-1.40%)
At close: Mar 28, 2025, 3:59 PM
1.40
-0.36%
After-hours: Mar 28, 2025, 04:05 PM EDT
ProQR Therapeutics Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -7.53 | -5.16 | -3.81 | -7.33 | -3.69 | -6.39 | -12.7 | -1.6 | -2.78 | -8.96 | -16.36 | -73.12 | n/a |
| PEG Ratio | 2.63 | 0.08 | 0.73 | -2.27 | 0.11 | -0.23 | 0.34 | -0.53 | -0.03 | 0.49 | -0.03 | n/a | n/a |
| PS Ratio | 11.05 | 22.28 | 61.32 | 333.90 | n/a | 187.60 | 94.83 | -45.62 | 47.60 | 19.83 | 634.02 | n/a | n/a |
| PB Ratio | 2.36 | 3.51 | 3.78 | 3.97 | 3.01 | 3.84 | 5.04 | 1.77 | 2.04 | 2.08 | 1.81 | -2.67K | n/a |
| P/FCF Ratio | -5.53 | 7.19 | -3.58 | -17.06 | -3.59 | -8.14 | -15.12 | -1.99 | -2.96 | -7.3 | -12.65 | -96.34 | n/a |
| P/OCF Ratio | -5.74 | 6.73 | -3.61 | -17.38 | -3.66 | -8.25 | -15.27 | -2 | -3.17 | -7.7 | -13.73 | -102 | n/a |
| OCF/S Ratio | -1.93 | 3.31 | -16.97 | -19.21 | n/a | -22.75 | -6.21 | 22.86 | -15 | -2.58 | -46.19 | n/a | n/a |
| Debt / Equity Ratio | 0.19 | 0.48 | 0.34 | 0.53 | 0.60 | 0.14 | 0.10 | 0.18 | 0.11 | 0.05 | 0.03 | -39.78 | 0.97 |
| Quick Ratio | 3.95 | 3.54 | 7.32 | 6.93 | 7.73 | 10.40 | 13.17 | 5.94 | 9.07 | 17.72 | 37.68 | 1.18 | 2.09 |
| Current Ratio | 3.95 | 3.54 | 7.32 | 6.94 | 7.77 | 10.43 | 13.28 | 5.95 | 9.24 | 17.82 | 37.79 | 1.18 | 2.09 |
| Asset Turnover | 0.11 | 0.05 | 0.02 | 0.01 | n/a | 0.02 | 0.04 | -0.03 | 0.03 | 0.09 | 0.00 | n/a | n/a |
| Interest Coverage | -28.29 | -26.48 | -12.62 | -16.8 | -20.77 | -53.04 | -44.81 | -67.95 | -73.56 | -68.36 | -62.12 | -85.24 | n/a |
| Return on Equity (ROE) | -0.31 | -0.68 | -0.99 | -0.54 | -0.82 | -0.6 | -0.4 | -1.11 | -0.74 | -0.23 | -0.11 | 36.55 | n/a |
| Return on Assets (ROA) | -0.17 | -0.2 | -0.38 | -0.29 | -0.47 | -0.48 | -0.33 | -0.82 | -0.6 | -0.21 | -0.11 | -0.72 | n/a |
| Return on Capital (ROIC) | -0.24 | -0.31 | -0.43 | -0.31 | -0.48 | -0.54 | -0.36 | -0.91 | -0.67 | -0.29 | -0.15 | -3.59 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 97.95% | 38.68% | 100.00% | n/a | -5.94K% | 80.09% | 165.49% | 43.84% | 94.87% | 100.00% | n/a | n/a |
| Net Profit Margin | -146.86% | -431.67% | -1.61K% | -4.56K% | n/a | -2.94K% | -746.69% | 2.85K% | -1.71K% | -221.45% | -3.87K% | n/a | n/a |
| Pretax Profit Margin | -147.9% | -426.97% | -1.61K% | -4.55K% | n/a | -2.93K% | -750.56% | 2.86K% | -1.71K% | -221.45% | -3.87K% | n/a | n/a |
| Operating Profit Margin | -161.18% | -489.09% | -1.6K% | -4.22K% | n/a | -2.97K% | -734.53% | 2.65K% | -1.73K% | -287.05% | -5.26K% | n/a | n/a |
| FCF Margin | -200.01% | 309.75% | -1.71K% | -1.96K% | n/a | -2.3K% | -627.28% | 2.29K% | -1.61K% | -271.67% | -5.01K% | n/a | n/a |
| EBITDA Margin | -127.6% | -369.93% | -1.4K% | -4.06K% | n/a | -9.02K% | -714.26% | n/a | -5.28K% | -895.55% | -15.88K% | n/a | n/a |